Biofrontera Inc. Proceeds from Issuance of Warrants
Biofrontera Inc. (BFRI) reported Proceeds from Issuance of Warrants of $4.63 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2022-11-14
- 2022-09-30: Proceeds from Issuance of Warrants 9 month $4.63M.
- 2022-07-14: Proceeds from Issuance of Warrants 0 month $2.00K.
| Period end | Proceeds from Issuance of Warrants 0 month | Proceeds from Issuance of Warrants 9 month |
|---|---|---|
| 2022-09-30 | $4.63M 10-Q · filed 2022-11-14 | |
| 2022-07-14 | $2.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |